Genetic differences between lung metastases and liver metastases from left-sided microsatellite stable colorectal cancer: next generation sequencing and clinical implications

Abstract

CNVs in primary tumors could identify patients with LuM. Targeting the HIPPO pathway or <i>MET</i> and immune checkpoint inhibitors (ICIs) combined with other agents might be novel therapies for LuM.